scholarly article | Q13442814 |
P50 | author | Kong I. Lie | Q110909004 |
P2093 | author name string | van Gilst WH | |
van Veldhuisen DJ | |||
Chin Kon Sung UG | |||
Corbeij HM | |||
de Vries RJ | |||
Dunselman PH | |||
P2860 | cites work | Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT) | Q28236958 |
Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects | Q34118531 | ||
Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 | ||
Efficacy of felodipine in congestive heart failure | Q41981403 | ||
Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction | Q43967888 | ||
Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography | Q44393881 | ||
A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure | Q44413313 | ||
Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. | Q54349860 | ||
Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. | Q54444203 | ||
Long-Term Clinical, Hemodynamic, Angiographic, and Neurohumoral Responses to Vasodilation with Felodipine in Patients with Chronic Congestive Heart Failure | Q67656826 | ||
The prevention of heart failure--a new agenda | Q68005740 | ||
Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study | Q68095078 | ||
Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy | Q68606433 | ||
Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies | Q69843944 | ||
Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure | Q69897587 | ||
Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril | Q70236791 | ||
Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies | Q71587602 | ||
Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris | Q72759897 | ||
Assessment of vasodilator therapy in patients with severe congestive heart failure: Limitations of measurements of left ventricular ejection fraction and volumes | Q72962779 | ||
CONTINUOUS MEASUREMENT OF VENTILATORY EXCHANGE RATIO DURING EXERCISE | Q76919557 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic heart failure | Q11829287 |
hemodynamics | Q1642137 | ||
P304 | page(s) | 159-164 | |
P577 | publication date | 1996-02-01 | |
P1433 | published in | Heart | Q856338 |
P1476 | title | Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure | |
P478 | volume | 75 |
Q77746911 | Calcium channel blockers in cardiac failure |
Q33738796 | Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study |
Q33755758 | Impact of calcium antagonists on the cardiovascular system: experience with lacidipine |
Q35549785 | Lacidipine: a review of its use in the management of hypertension |
Q31942459 | Meta-analysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure. |
Q33755752 | Role of a third generation calcium antagonist in the management of hypertension |
Q41750388 | The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal |
Search more.